163 related articles for article (PubMed ID: 9372024)
1. Treatment of the hemophilias.
Moll S; White GC
Curr Opin Hematol; 1995 Sep; 2(5):386-94. PubMed ID: 9372024
[TBL] [Abstract][Full Text] [Related]
2. Transfusion-transmitted disease.
Lee CA
Baillieres Clin Haematol; 1996 Jun; 9(2):369-94. PubMed ID: 8800511
[TBL] [Abstract][Full Text] [Related]
3. [Current clinical aspects in hemophilia treatment].
Meili EO
Schweiz Med Wochenschr; 1989 Sep; 119(39):1332-41. PubMed ID: 2508219
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of viral safety of coagulation factor VIII and IX concentrates.
Mannucci PM
Vox Sang; 1993; 64(4):197-203. PubMed ID: 8517048
[TBL] [Abstract][Full Text] [Related]
5. Prions and haemophilia: assessment of risk.
Evatt BL
Haemophilia; 1998 Jul; 4(4):628-33. PubMed ID: 9873805
[TBL] [Abstract][Full Text] [Related]
6. Surveillance for transfusion-transmitted viral infections in the United States.
Chamberland ME
Biologicals; 1998 Jun; 26(2):85-8. PubMed ID: 9811510
[TBL] [Abstract][Full Text] [Related]
7. Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization.
Santagostino E; Mannucci PM; Gringeri A; Azzi A; Morfini M; Musso R; Santoro R; Schiavoni M
Transfusion; 1997 May; 37(5):517-22. PubMed ID: 9149778
[TBL] [Abstract][Full Text] [Related]
8. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
[TBL] [Abstract][Full Text] [Related]
9. Viral safety of plasma-derived factor VIII and IX concentrates.
Ludlam CA
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S19-23. PubMed ID: 9351532
[TBL] [Abstract][Full Text] [Related]
10. Safety trial of heated factor VIII concentrate (8Y).
Pasi KJ; Hill FG
Arch Dis Child; 1989 Oct; 64(10):1463-7. PubMed ID: 2510607
[TBL] [Abstract][Full Text] [Related]
11. Clinical spectrum of viral infections in hemophilic patients.
Telfer MC
Hematol Oncol Clin North Am; 1992 Oct; 6(5):1047-56. PubMed ID: 1328142
[TBL] [Abstract][Full Text] [Related]
12. Complex dental extractions in a patient with severe haemophilia A and inhibitors treated with activated prothrombin complex concentrate.
Zanon E; Brandolin B; Saggiorato G; Bacci C
Blood Transfus; 2012 Apr; 10(2):225-7. PubMed ID: 22337269
[No Abstract] [Full Text] [Related]
13. Prospective study of the evaluation of hepatitis C virus infectivity in a high-purity, solvent/detergent-treated factor VIII concentrate: parallel evaluation of other markers for lipid-enveloped and non-lipid-enveloped viruses. The Ad Hoc Study Group of the Fondazione dell'Emofilia.
Mariani G; Di Paolantonio T; Baklaya R; Morfini M; Mannucci PM
Transfusion; 1993 Oct; 33(10):814-8. PubMed ID: 8236421
[TBL] [Abstract][Full Text] [Related]
14. Surveillance for Creutzfeldt-Jakob disease among persons with hemophilia.
Evatt B; Austin H; Barnhart E; Schonberger L; Sharer L; Jones R; DeArmond S
Transfusion; 1998 Sep; 38(9):817-20. PubMed ID: 9738620
[TBL] [Abstract][Full Text] [Related]
15. [Prevention of transfusion-associated virus infections in hemophilic patients needing replacement therapy].
Meili EO
Beitr Infusionsther; 1989; 24():46-55. PubMed ID: 2481548
[TBL] [Abstract][Full Text] [Related]
16. [Viral hepatitis following administration of the 4 coagulation-factors concentrate PPSB].
Penn HJ
Ned Tijdschr Geneeskd; 1979 Sep; 123(35):1532-3. PubMed ID: 492370
[No Abstract] [Full Text] [Related]
17. Infection with hepatitis G virus among recipients of plasma products.
Jarvis LM; Davidson F; Hanley JP; Yap PL; Ludlam CA; Simmonds P
Lancet; 1996 Nov; 348(9038):1352-5. PubMed ID: 8918279
[TBL] [Abstract][Full Text] [Related]
18. Preventing bleeds by treatment: new era for haemophilia changing the paradigm.
Marijke van den Berg H
Haemophilia; 2016 Jul; 22 Suppl 5():9-13. PubMed ID: 27405669
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy and the hemophilias.
Lozier JN; Brinkhous KM
JAMA; 1994 Jan; 271(1):47-51. PubMed ID: 8258886
[TBL] [Abstract][Full Text] [Related]
20. Transfusion therapy in congenital coagulopathies.
Lusher JM
Hematol Oncol Clin North Am; 1994 Dec; 8(6):1167-80. PubMed ID: 7860443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
